Skip to content

Checked

Class IDrug recallTerminated

Ascorbic Acid Inj. Solution recall

Recalled by Staska Pharmaceuticals, Inc. of Bennet, NE · FDA report 11/13/2024

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class I
Most serious
Status
Terminated
Closed 08/05/2025
Recall started
09/30/2024
Distribution
Nationwide

Reason for recall

Presence of Particulate Matter: Presence of glass particulates.

Class I: A reasonable chance that using or being exposed to the product will cause serious health problems or death.

Recalled product

Product
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Lot and code info
Lot #SP2400058, Exp 12/31/2024
Quantity
4773 vials
Recall number
D-0040-2025
Event ID
95503
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the USA

  • Nationwide

Recall timeline

  1. 09/30/2024Firm started the recall
  2. 11/07/2024FDA classified it as Class I
  3. 11/13/2024Published in the FDA enforcement report
  4. 08/05/2025FDA closed (terminated) the recall

Frequently asked questions

Why was Ascorbic Acid Inj. Solution recalled?
Presence of Particulate Matter: Presence of glass particulates.
What does Class I mean?
Class I is FDA's most serious recall category: a reasonable chance that using or being exposed to the product will cause serious health problems or death.
Where was the recalled product sold?
Nationwide in the USA
Is this recall still active?
The FDA lists the recall as terminated (closed 08/05/2025). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 11/13/2024 · Do not rely on openFDA to make decisions regarding medical care